Table 2

Studies demonstrating faecal shedding of SARS-CoV-2

StudyRegionPatients with positive stool/rectal sample (n)Duration of positive infection (in days)Patients with positive stool/rectal samples after negative respiratory samples (n)
Adult studies
 Kujawski et al 13 USA7/12 (58.3%)1–121/7 (14.3%)
Joukar et al 15 Guilian province, Iran6/100 (6%)8–42NA
Lin et al 17 Guangzhou, China46/217 (21.2%)3–1830/46 (65.2%)
Lo et al 21 Macau, China9/9 (100%)1–181/9 (11.1%)
Zhao et al 22 China80/401 (19.95%)NANA
Chen et al 23 Wuhan, China28/42 (66.67%)NA18/28 (64.29%)
Paediatric studies
Xu et al 16 Gangzhou, China8/10 (80%)3–288/8 (100%)
Liu et al 18 Shanghai, China8/9 (89%)28–668/8 (100%)
Huang et al 19 Zhejiang, China11/16 (69%)NANA
Han et al 20 Wuhan,China12/22 (54.5%)80% positive
>3 weeks
NA